Background and Objective: Surgery is the main therapy for patients with stage-ll non-small cell lung cancer (NSCLC), but patients still have an unsatisfactory prognosis even though complete resection is usually possible. Adjuvant chemotherapy provides low rates of clinical benefit as well. We retrospectively analyzed prognostic factors of patients with completely resected stage-ll NSCLC to find patients with unfavorable factors for proper management. Methods: Clinical data of 220 patients with complete resections of stage-ll NSCLC at the Sun Yat-sen University Cancer Center between January 1998 and December 2004 were retrospectively analyzed. Cumulative survival was analyzed by the Kaplan-Meier method and compared by log rank test. Prognosis was analyzed by the Cox proportional hazards model. Results: The overall 3- and 5-year survival rates were 58.8

作者：戴云；苏晓东；龙浩；Peng Lin；Jian-Hua Fu；Lan-Jun Zhang；Xin Wang；Zhe-Sheng Wen；Zhi-Hua Zhu；Xu Zhang；Tie-Hua Rong

来源：癌症 2010 年 29卷 5期